Blockade of patch-based μ opioid receptors in the striatum attenuates methamphetamine-induced conditioned place preference and reduces activation of the patch compartment The behavioral effects of methamphetamine (METH) are mediated by the striatum, which is divided into the patch compartment, which mediates limbic and reward functions, and the matrix compartment, which mediates sensorimotor tasks. METH treatment results in repetitive behavior that is related to enhanced relative activation of the patch versus the matrix compartment. The patch, but not the matrix compartment contains a high density of μ opioid receptors, and localized blockade of patch-based μ opioid receptors attenuates METH-induced patch-enhanced activity and repetitive behaviors. Numerous studies have examined patch-enhanced activity and the contribution of patch-associated μ opioid receptors to METH-induced repetitive behavior, but it is not known whether patch-enhanced activity occurs during METH-mediated reward, nor is it known if patch-based μ opioid receptors contribute to METH reward. The goals of this study were to determine if blockade of patchbased μ opioid receptors alters METH-induced conditioned place preference (CPP), as well activation of the patch and matrix compartments following METH-mediated CPP. A biased conditioning paradigm was used to assess CPP, and conditioning occurred over an 8-d period. Animals were bilaterally infused in the striatum with the μ-specific antagonist CTAP or vehicle prior to conditioning. Animals were tested for preference 24 h after the last day of conditioning, sacrificed and the brains processed for immunohistochemistry. Blockade of patchbased μ opioid receptors reduced METH-induced CPP, and reduced patch-enhanced c-Fos expression in the striatum following METH-mediated CPP. These data indicate that patch-enhanced activity is associated with METH-mediated reward and patch-based μ opioid receptors contribute to this phenomenon.
Introduction
The striatum mediates the behavioral effects of psychostimulants, and can be divided into the patch (striosome) and matrix compartments based on differences in neurochemistry and neuroanatomy. The spiny neurons of the patch compartment express a high density of μ opioid receptors, while the spiny neurons of the matrix compartment express few μ opioid receptors, but are enriched in calbindin (Gerfen et al., 1985; Herkenham and Pert, 1981; Pert et al., 1976) . The patch compartment receives input from limbic cortices, and projects almost exclusively to the substantia nigra pars compacta (SNpc), which sends dopaminergic inputs back to the striatum (Fujiyama et al., 2011; Gerfen, 1984; Tokuno et al., 2002) , while the matrix compartment receives input from sensorimotor cortices and comprises the majority of the direct and indirect pathways that mediate movement (Crittenden and Graybiel, 2011; Fujiyama et al., 2011; Gerfen, 1984 Gerfen, , 1989 . Based on these differences, the activity of the patch and matrix compartments are likely regulated by diverse mechanisms, and mediate different aspects of behavior.
While the matrix compartment is related to sensorimotor processing, the limbic-based circuits of the patch compartment mediate repetitive behaviors such as psychostimulant-induced stereotypy (Canales, 2005; Canales and Graybiel, 2000; Crittenden and Graybiel, 2011) . Enhanced relative activation of the patch versus matrix compartment is observed during psychostimulant-induced stereotypy, and the degree of stereotypy is positively correlated with patch-enhanced activation in dorsolateral striatum . Since the patch compartment has dense connectivity with regions that process emotional information, stereotypy is likely the due to the enhanced relative activation of patch-based circuits, resulting in behaviors that are driven by internal emotional states, at the expense of switching to adaptive behaviors based on the external environment (Aliane et al., 2009; Canales, 2005; Canales and Graybiel, 2000; Crittenden and Graybiel, 2011) . The relative enhanced activation of the patch compartment could contribute to the development of habitual drug abuse, due to the interactions of the patch compartment with regions that mediate reinforcement and relapse into drug-seeking behavior (Canales, 2005) . Of note, previous work has shown that animals will repeatedly electrically self-stimulate when electrodes are placed in or near the patch compartment, supporting the notion that this region plays a role in processes that guide motivation and reward learning (White and Hiroi, 1998) . However, whether enhanced relative activation of the patch versus matrix compartment is associated with psychostimulant-mediated reward is unknown, and the mechanisms that contribute to patch-enhanced activity during psychostimulantmediated reward not identified.
Striatal μ opioid receptors, since they are expressed specifically on the neurons of the patch compartment are in an optimal position to modulate the activity of this region. Our previous work indicated that blockade of striatal μ opioid receptors attenuated patch-enhanced activation and stereotypy following METH treatment (Horner et al., 2010) . While it has been shown that central μ opioid receptors modulate psychostimulant-mediated reward (Schroeder et al., 2007) , the specific contribution of patch-based μ opioid receptors is unknown. These data indicate that μ opioid receptors play a role in the activation of neurons of the patch compartment following psychostimulant treatment, as well as psychostimulant-induced behaviors. However, whether patch-based μ opioid receptors contribute to patch-enhanced activation in the context of METH-mediated reward has not been examined. The goals of this study were to determine if patch-enhanced activity is associated with METH-mediated reward, and whether patchbased μ opioid receptors contribute to this phenomenon.
Materials and methods

Drugs
( ± )METH-HCl was generously provided by the National Institute on Drug Abuse, and injected subcutaneously in a volume of 1 ml/kg body weight. The dose of METH (2 mg/kg; (Suzuki and Misawa, 1995) ) was based on the weight of the salt. The μ opioid receptor antagonist CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr) was obtained from Tocris Bioscience (Minneapolis, MN, USA) and dissolved in sterile buffered artificial cerebrospinal fluid (aCSF; 144 mM NaCl; 2.68 mM KCl; 1.6 mM CaCl 2 ; 2.6 mM MgCl 2 ; 0.4 mM KH 2 PO 4 , pH, 7.2) at 0.8 μg/μl (Schroeder et al., 2007) .
Animals and surgery
Male Sprague-Dawley rats (Charles River Laboratories, Raleigh, NC, USA), weighing 250-350 g were used in all experiments. Rats were housed in plastic cages in a temperature-controlled room on a 14:10 h light/dark cycle with free access to food and water. All animal care and experimental manipulations were approved by the Institutional Animal Care and Use Committee of Mercer University School of Medicine and were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The minimum possible number of animals (based on power analyses) was used for our experiments and measures were taken to minimize any suffering that might occur during our procedures.
One week after arrival at our facility, rats underwent surgery for the placement of bilateral indwelling intrastriatal cannulae. Rats were anesthetized with ketamine (90 mg/kg, i.p.) and xylazine (9 mg/kg, i.p.) and stainless steel 26-gauge guide cannulae 3.5 mm in length (Plastics One, Roanoke, VA, USA) were implanted bilaterally, based on the coordinates of Paxinos and Watson ( Paxinos and Watson, 2005 ) in the rostral striatum, at +1.5 mm from bregma, ± 3.0 mm lateral to midline and 3.5 mm below the surface of the skull. The cannulae were secured to the skull with dental acrylic and anchored with stainless steel surgical screws inserted into the skull. The guide cannulae were kept patent with 31-gauge obturators that were the same length as the guides. Rats were allowed to recover for 2-3 days before the start of the experiment. Only rats whose cannulae were in the rostral striatum were included in subsequent analyses.
Conditioned place preference (CPP)
Conditioning chambers consisted of a 30×30×30-cm Plexiglass chamber divided into two distinct compartments separated by a removable partition. One compartment had solid gray walls, while the other compartment had vertical alternating black and white stripes that were 2.5 cm wide. Floors were stainless steel wire mesh of differing mesh size to provide differential tactile cues. One day before the start of the conditioning procedure, rats were habituated chambers for 30 min with the partition removed. Twenty-four h later, the rats were returned to the chambers for 20 min with the partition removed, and the time on each side recorded to determine each animal's initial bias. Conditioning began the next day, and consisted of 8 days of alternating saline or METH injections, with rats confined to the preferred side, as determined by the preconditioning bias test, on saline exposure days (days 1, 3, 5 and 7 of conditioning,), and the initially non-preferred side on drug exposure days (days 2, 4, 6, and 8 of conditioning; (Nygard et al., 2015) ). Rats were randomly assigned to one of four groups: vehicle/ saline, vehicle/METH, CTAP/saline, or CTAP/METH. Prior to each conditioning session, the dummy cannulae were removed and 31-gauge stainless steel injection cannulae that extended 1.5 mm beyond the guide were inserted into the guide cannulae. A 5-μl volume of aCSF or CTAP (4 μg/5 μl; (Schroeder et al., 2007) ) was administered bilaterally at a rate of 1.0 μl/minute to the freely moving animal. After each infusion, the injection cannulae were left in place for 1 min in order to minimize fluid back flow through the cannulae. Twenty min later, each rat received an injection of saline or METH, and was immediately confined to the conditioning chamber for 30 min. On drug exposure days (i.e., days 2, 4, 6 and 8 in the initially non-preferred chamber), rats in the vehicle/METH and vehicle/saline groups were intrastriatally infused with aCSF, while animals in the CTAP/METH and CTAP/saline groups were intrastriatally infused with CTAP prior to their injections (Schroeder et al., 2007) . On saline exposure days (i.e., days 1, 3, 5 and 7 in the initially preferred chamber) all groups of rats were infused with aCSF prior to injection with saline (Schroeder et al., 2007) . Twentyfour h after the last conditioning session, rats underwent preference testing, with rats in the drug-free state given free access to both chambers for 20 min. The difference in seconds between the time spent in the METH-paired compartment during the preference testing and the time spent in the same initially non-preferred compartment during the bias testing prior to starting the conditioning procedure was used to calculate the degree of place conditioning (Schroeder et al., 2007) . For saline-treated rats, preference was calculated as the difference in seconds between the time spent in the initially non-preferred compartment during the preference testing and the time spent in the same nonpreferred compartment prior to conditioning, as previously described (Schroeder et al., 2007) . A positive preference score indicates a conditioned place preference, while a negative preference score is indicative of a conditioned place aversion (Schroeder et al., 2007) . Both the bias test and preference test sessions were digitally recorded and analyzed post-hoc using AnyMaze software. In order to determine whether differences in locomotor activity may have contributed to the animals' behavior in the CPP, post-hoc analysis of the distance traveled during the preference test was analyzed using AnyMaze software.
Tissue processing for immunohistochemistry
Thirty min after preference testing, rats were killed by exposure to CO 2 for 1 min followed by decapitation. The brains were rapidly harvested, flash-frozen in isopentane and stored at −80°C until they were cut into 12-μm sections through the striatum at the level of the infusion (approximately +1.5 mm anterior to bregma (Paxinos and Watson, 2005) ) on a cryostat (Minotome Plus, Triangle Biomedical Sciences, Durham, NC, USA).
c-Fos immunohistochemistry
Sections were post-fixed in 4% paraformaldehyde, pH 7.4 and then rinsed three times in phosphate-buffered saline (PBS). Slides were then blocked with 4% normal goat serum (NGS)/0.3% Triton X-100 (TX) for 1 h followed by overnight incubation at 4°C with a polyclonal antibody for c-Fos (Abcam, Cambridge, MA, USA), diluted in 1:1000 in 0.3% TX/0.1 M PBS. The slides were then washed several times in PBS and incubated for 2 h at room temperature in biotinylated goat anti-rabbit IgG antiserum (Vector Laboratories, Burlingame, CA, USA) diluted 1:200 in 0.1 M PBS/1% NGS. Slides were then washed three times in PBS, incubated 1 h in ABC solution (Elite ABC Kit, Vector Laboratories) and washed three more times in PBS. Bound antibody was detected using a 3,3′-diaminobenzidine/Ni + solution (Vector Laboratories). Slides were washed with deionized H 2 O, dehydrated in a series of alcohols and coverslipped out of xylene.
μ opioid receptor immunohistochemistry
Sections that were 12-μm from the sections labeled for c-Fos were labeled for the μ opioid receptor in order to delineate the patch and matrix compartments. Sections were post-fixed in 4% paraformaldehyde/0.9% NaCl and rinsed three times in 0.1 M PBS. Slides were then blocked with 10% bovine serum albumin (BSA)/0.3% TX/0.1 M PBS for 2 h followed by overnight incubation at 4°C with a polyclonal antibody for the μ opioid receptor (Immunostar, Hudson, WI, USA), diluted in 1:1000 in 0.3% TX/0.1 M PBS/5% BSA. The slides were then washed several times in PBS and incubated for 2 h at room temperature in biotinylated goat anti-rabbit IgG antiserum (Vector Laboratories) diluted 1:200 in 0.1 M PBS/5% BSA. Slides were then washed three times in PBS, incubated 1 h in ABC solution (Elite ABC Kit, Vector Laboratories) and washed three more times in PBS. Bound antibody was detected using a 3,3′-diaminobenzidine/Ni + solution (Vector Laboratories). Slides were washed with deionized H 2 O, dehydrated in a series of alcohols and coverslipped out of xylene.
Image analysis
c-Fos-labeled sections and the adjacent μ opioid receptor-labeled sections (7-10 animals/treatment group) were captured by a VistaVision microscope (VWR, Radnor, PA, USA) with a video camera (CCD Moticam 2300, Motic, Richmond, BC, Canada) using a 4x objective. Image J was used to outline regions of either dense μ opioid receptor immunoreactivity (patch) or absent μ opioid receptor immunoreactivity (matrix), which were superimposed over the corresponding areas of the adjacent c-Fos-labeled striatal section (Murray et al., 2014 (Murray et al., , 2015 . The number c-Fos-labeled particles that exceeded the threshold density in each region of interest was determined using the particle analysis option in Image J. Prior to analysis, the pixel range for particle size was determined by outlining approximately 15-20 positively labeled cells from 10 to 15 randomly selected sections and determining the average size of the labeled cells in terms of pixel area. The lower limit for a ''labeled cell'' on the particle analysis setting was then set to the smallest number of pixels measured for any cell, whereas the upper limit was set at the maximal particle size on the particle analysis option on Image J. The threshold density was adjusted such that background staining was eliminated and the number of immunoreactive pixels per the selected area in each region of interest was measured above this threshold. Counts of c-Fos-labeled particles were expressed as the number c-Fos-immunoreactive particles per mm 2 .
Statistical analysis
The effects of μ opioid receptor blockade on METH-induced CPP, locomotor activity, c-Fos immunoreactivity in the patch and matrix compartments and the ratio of patch-to-matrix c-Fos immunoreactivity (which was calculated by dividing the number of c-Fos immunoreactive particles/mm 2 in the patch divided by the number of c-Fos immunoreactive particles/mm 2 in the matrix for each animal) was analyzed using a two-way (pre-treatment x treatment condition) analysis of variance. Post-hoc analysis of significant effects was accomplished using individual Bonferroni (Dunn) t-tests. The alpha level for all analyses was set at 0.05. In the case of a significant overall main effect of treatment, the alpha level was not corrected, as only one comparison was made in the post-hoc analysis (SAL vs. METH). For the post-hoc analysis of significant interaction terms, four comparisons were made (VEH/SAL vs. VEH/METH; VEH/SAL vs. CTAP/SAL; VEH/METH vs. CTAP/METH; CTAP/SAL vs. CTAP/METH), thus requiring a pvalue=0.0125 (0.05/4) for statistical significance. A one-sample t-test against zero was also used to determine whether a significant place preference or aversion was observed following treatment (Schroeder et al., 2007) .
Results
The effects of patch-based μ opioid receptor blockade on METHinduced CPP
CPP was used to assess the role of μ opioid receptors expressed on the neurons of the patch compartment in the development of METH reward. A two-way analysis of variance of the preference scores, which were generated by calculating the difference in the amount of time spent in the drug-paired chamber vs. the amount of time spent in the initially preferred chamber (Schroeder et al., 2007) , revealed a significant main effect of CTAP pretreatment (F 1, 29 =5.704, P=0.024), a significant main effect of METH treatment (F 1, 29 =5.601, P=0.025) and a significant pretreatment x treatment interaction (F 1, 29 =7.542; P=0.01; Fig. 1 ). Post-hoc analysis revealed that METH treatment induced a significant place preference in VEH-pretreated animals, as compared to VEH-pretreated, saline-treated animals (P=0.005; 3.2. The effects of patch-based μ opioid receptor blockade on c-Fos expression in the patch and matrix compartments following METHinduced CPP
The development of METH-induced CPP appeared to increase cFos immunoreactivity in the patch compartment relative to the matrix, an effect that was reduced by pre-treatment with CTAP (Fig. 2) . Quantitative analysis of c-Fos immunoreactivity in the patch compartment, followed by a two-way analysis of variance revealed significant main effects of CTAP pretreatment (F 1,26 =7.07; P=0.0132) and METH treatment (F 1,26 =5.57; P=0.026), as well as a significant pretreatment x treatment interaction (F 1, 26 =10.79; P=0.0029). Post-hoc analysis revealed that there was a significant increase in the number of c-Fos immunoreactive particles/mm 2 in the patch compartment of VEHpretreated, METH-treated animals, as compared to VEH-pretreated, saline-treated animals (P=0.0032; t=3.55). Pretreatment with CTAP significantly reduced the number of c-Fos immunoreactive particles/ mm 2 in the patch compartment of METH-treated animals, as there was a significant difference between VEH/METH and CTAP/METH groups (P=0.010; t=3.12). There was no significant difference between in the number of c-Fos immunoreactive particles/mm 2 in the patch compartment for CTAP/METH vs. CTAP/SAL groups (P=0.461; t=0.913), nor did CTAP treatment alone significantly alter the number of c-Fos immunoreactive particles/mm 2 in the patch compartment (P=0.68; t=0.422; Fig. 3 ). Quantitative analysis of the number of c-Fos immunoreactive particles in the matrix compartment, followed by a two-way analysis of variance, revealed a significant main effect of METH treatment (F 1,33 =6.08; P=0.019), but no significant effect of CTAP pretreatment (F 1,33 =0.222; P=0.640) and no significant pretreatment x interaction (F 1,33 =0.23; P=0.66). Post-hoc analysis revealed that METH treatment decreased the number of c-Fos immunoreactive particles/mm 2 in the matrix compartment regardless of the pretreatment that was given (P=0.021; t=2.43). The data indicate that blockade of patch-based μ opioid receptors reduces the activation of patch compartment following METH-mediated reward (Fig. 3) .
3.3. The effects of patch-based μ opioid receptor blockade on the relative activation of the patch vs. matrix compartments following METH-induced CPP METH-mediated CPP was associated with increased c-Fos immunoreactivity in the patch compartment and a down-regulation of c-Fos immunoreactivity in the matrix compartment, and the relative level of compartmental activation differed as shown by the ratio of patch-tomatrix c-Fos immunoreactivity (Fig. 4) . Two-way analysis of variance of the patch-to-matrix ratio of c-Fos immunoreactivity revealed significant main effects of CTAP pretreatment (F 1,32 =19.29; P=0.0001) and METH treatment (F 1,32 =20.62; P < 0.0001), and a significant pretreatment x treatment interaction (F 1,23 =16.25; P=0.0003). Post-hoc analysis of significant effects found that there was a significant increase in the ratio of patch-to-matrix c-Fos immunoreactivity in VEH-pretreated, METH-treated animals, as compared to VEH-pretreated, SAL-treated animals (P=0.0002; t=4.78). Pretreatment with CTAP attenuated the METH-induced ratio of patchto-matrix c-Fos immunoreactivity, as post-hoc analysis also revealed that there was a significant difference in the ratio of patch-to-matrix cFos immunoreactivity between VEH-pretreated, METH-treated animals, and CTAP-pretreated, METH treated animals (P=0.0004; t=4.68). The ratio of patch-to-matrix c-Fos immunoreactivity was not significantly different between CTAP-pretreated, SAL-treated animals and CTAP-pretreated, METH-treated animals (P=0.511; t=0.673), nor was there a difference between VEH-pretreated, SAL-treated animals and CTAP-pretreated, SAL-treated animals (P=0.683; t=0.414). These data indicate that following METH-mediated reward, the relative activation of the patch compartment is enhanced as compared to the matrix compartment, and blockade of patch-based μ opioid receptors can attenuate this effect by reducing c-Fos activation within the patch compartment.
Discussion
The goals of this study were to determine if a pattern-enhanced pattern of activation in the striatum is associated with METH-mediated reward and the contribution of patch-based μ opioid receptors. A patch-enhanced pattern of activation was observed in the rostral striatum following METH-induced CPP, as c-Fos levels were increased in the patch compartment and decreased in the matrix compartment in animals that underwent METH-mediated CPP. Intrastriatal administration of CTAP attenuated METH-induced CPP and diminished the patch-enhanced pattern of activation associated with METH-induced CPP. These data indicate that METH-mediated reward is associated with preferential enhancement of patch-based circuits, and that activation of patch-based μ opioid receptors during METH exposure contributes to the enhanced relative activity of the patch compartment, and the development of METH-mediated reward association.
Numerous studies have shown that enhanced activation of the patch compartment relative to the matrix compartment is observed during psychostimulant-induced stereotypy, and our studies have shown that an intact patch compartment is necessary for the expression of repetitive behaviors induced by psychostimulants (Adams et al., 2003; Canales and Graybiel, 2000; Graybiel et al., 1990; Horner et al., 2012 Horner et al., , 2010 Horner and Keefe, 2006; Jedynak et al., 2012; Murray et al., 2014; Saka et al., 2004; Wang et al., 1995) . The current study is the first that demonstrate that drug-mediated reward is also associated with enhanced activation of the patch compartment relative to the matrix compartment. Enhanced relative activation of the patch compartment may play a role in habit learning, including maladaptive behaviors such as addiction, although to date no study has directly examined this hypothesis (Canales, 2005; Canales and Graybiel, 2000) . While the nucleus accumbens has received the most attention regarding reward, the compulsive and rigid behaviors that are typical of addiction are in line with the types of compulsive and habitual Data are shown as the mean ( ± S.E.M.) distance traveled (in meters) during the preference test. There was no significant difference in the distance traveled between any of the groups.
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Fig. 2. Effects of intrastriatal infusion of CTAP on c-Fos immunoreactivity in the patch and matrix compartments following METH-mediated CPP. Representative photomicrographs showing μ opioid receptor and c-Fos immunoreactivity in adjacent sections that are 12 µm apart. μ opioid receptor immunoreactivity was used to delineate the patch from the matrix compartments, as μ opioid receptors are preferentially expressed in the patch compartment. Scale bar=100 µm. Horner et al. European Journal of Pharmacology 796 (2017) 207-214 behaviors that are mediated by basal ganglia circuits through the striatum. A number of studies have shown that the dorsolateral striatum is a key region for the development of habitual behaviors, and pharmacologically induced repetitive and fixed behaviors are associated with patch-enhanced activation specifically in the dorsolateral striatum Yin et al., 2004) . It is possible that the initial learning processes involving drug-seeking behaviors may rely on the nucleus accumbens, but as the behavior becomes more rigid and fixed, drug-seeking behaviors may become more reliant on the dorsolateral striatum (Berke and Hyman, 2000; Canales, 2005; Hyman and Malenka, 2001; Natarajan and Yamamoto, 2011; Robbins and Everitt, 2002; Voorn et al., 2004) . In support this notion, following extended psychostimulant self-administration the presentation of a conditioned stimulus previously paired with the drug alters dopamine release in the dorsolateral striatum, but not in the nucleus accumbens (Vanderschuren and Kalivas, 2000) . Furthermore, ascending recurrent interconnected loops exist between the nucleus accumbens and the dorsolateral striatum via midbrain dopamine neurons, indicating that an anatomical pathway exists for the transfer of limbic information to regions that mediate habitual learning (Haber et al., 2000) . This system could participate in transferring limbicrelated information to the patch compartment, resulting in a shift in control of actions that were once mediated by the mesolimbic dopamine system to patch-based pathways. In addition, the activation of the patch compartment has been shown to be rewarding, as animals will self-stimulate when an electrode is placed in or near the patch compartment, indicating that motivational states may be facilitated by the patch compartment (White and Hiroi, 1998) . It is possible that as drug-seeking behaviors become more stimulus-response in nature that patch-based circuits in the dorsolateral striatum participate by conveying and assigning limbic information about internal and motivational states to habit formation. Thus, the patch-based limbic circuits that traverse the striatum, particularly in the dorsolateral region may contribute to behaviors that are linked to motivational states, with the patch compartment potentially serving as a node of contact between the limbic system and basal ganglia whereby internally driven states can affect basal-ganglia mediated adaptive behavioral functions.
It is important to note that the enhanced activation of the patch compartment relative to the matrix compartment observed following METH-mediated CPP is the result of an increase in c-Fos levels in the patch compartment coupled with a down-regulation of c-Fos levels in the matrix compartment. These findings are in line with previous work where a down-regulation of c-Fos activity in the matrix compartment was observed repeated exposure to psychostimulants contributing to a patch-enhanced pattern of activation . It is thought that repeated exposure to psychostimulants leads to longterm depression (LTD) in the matrix compartment, although this hypothesis has not been explored (Canales, 2005; Canales and Graybiel, 2000; Graybiel et al., 2000) . The sensorimotor cortex, which sends projections primarily to the matrix compartment is strongly activated by psychostimulant treatment O'Dell and Marshall, 2000) . It is possible that a progressive depression of glutamatergic corticostriatal inputs could contribute to LTD in the matrix compartment, which may be reflected in the down-regulation of c-Fos activity in this region O'Dell and Marshall, 2000) . Recent work indicates that μ opioid receptors in the patch compartment may also modulate neuroplasticity in the matrix compartment. Miura and co-workers found that activation of patchbased μ opioid receptors inhibits presynaptic GABAergic release only in the patch compartment (Miura et al., 2008 (Miura et al., , 2007 . The source of these μ-sensitive GABA inputs are most likely μ opioid receptor-expressing neurons in the patch compartment that send GABAergic collaterals to neighboring medium spiny neurons and to cholinergic interneurons located on the patch-matrix borders (Czubayko and Plenz, 2002; Tunstall et al., 2002; Venance et al., 2004) . Activation of patch-based μ opioid receptors suppresses GABA transmission and releases neigh- boring medium spiny neurons and cholinergic interneurons from inhibition, which through several mechanisms, leads to a pause in the tonic firing of cholinergic interneurons, and ultimately LTD in the neurons of the matrix compartment (Miura et al., 2008 (Miura et al., , 2007 . However, while our data indicates that c-Fos activity is decreased in the matrix compartment following METH-mediated CPP, blockade of patch-based μ opioid receptors did not reverse the decrease in c-Fos levels in the matrix. Thus, in the context of METH-mediated CPP, the effects of μ opioid receptor blockade appear to be confined to the neurons of the patch, with little effect on the neurons of the matrix compartment. Clearly, additional studies are needed in order to determine whether LTD occurs in the neurons of the matrix compartment following repeated psychostimulant exposure, and whether patch-based μ opioid receptors contribute to this process. While μ opioid receptor activation is most often associated with neuronal inhibition (Alreja and Aghajanian, 1993) , μ opioid receptor activation may also have excitatory effects on cellular activity, as μ opioid receptor activation can induce mitogen-activated kinasemediated intracellular cascades, cyclase-response element activity, and c-Fos activity (Bilecki et al., 2004; Shoda et al., 2001 ). Blockade of patch-based μ opioid receptors may decease neuronal activation of these neurons, and directly inhibit of c-Fos expression during METHmediated CPP, and diminish output from patch-based limbic circuits, although the specific circumstances that determine whether the effects of μ opioid receptor activation are excitatory or inhibitory are unclear. Alternatively, patch-based μ opioid receptors may modulate dopamine release within the striatum (Gonzalez-Nicolini et al., 2003) . The GABAergic neurons of the patch compartment project exclusively to the dopamine neurons of the SNpc, which project back to the striatum (Fujiyama et al., 2011; Gerfen, 1984; Jimenez-Castellanos and Graybiel, 1987; Tokuno et al., 2002) . Blockade of μ opioid receptors may disinhibit the neurons of the patch compartment, leading to increased GABA-mediated inhibition of nigrostriatal neurons, and diminished c-Fos expression. However, this scenario is unlikely as the SNpc sends dopaminergic inputs to both the patch and matrix compartment, which would result in μ opioid receptor-mediated changes in c-Fos in both compartments (Fujiyama et al., 2011; Gerfen, 1984; Jimenez-Castellanos and Graybiel, 1987; Tokuno et al., 2002) . In addition, amphetamine-induced dopamine release is nonaction potential dependent, and therefore, changes in the neuronal excitability of nigrostriatal neurons by patch-based μ opioid receptor blockade most likely would not impact dopamine release in the striatum (Nomikos et al., 1990) . Future studies focusing on the specific mechanisms by which patch-based μ opioid receptors alter the activation of the patch compartment, and modulate nigrostriatal dopamine release will shed light on this issue.
As mentioned above, patch-based neurons send inhibitory projections to dopamine neurons in the SNpc (Fujiyama et al., 2011; Gerfen, 1984; Tokuno et al., 2002) . These dopamine neurons typically respond to novel and reinforcing stimuli, such as drugs, thus promoting reinforcement learning (Fiorillo et al., 2003) . The inhibitory control of these dopamine neurons by the neurons of the patch compartment may prevent dopamine release in response to expected reinforcers, which could lead to the development of well-learned behaviors that become more dependent on internal reinforcing states, and less dependent on external stimuli for its maintenance (Canales, 2005) . Furthermore, electrical activation of the patch compartment in vivo is rewarding, and can drive instrumental behaviors (White and Hiroi, 1998) . Thus, blockade of patch-based μ opioid receptors and the resulting decrease in activity of patch compartment neurons may lead to less dependence of well-learned behaviors (such as METH-mediated CPP) on internal motivational states and diminished reward.
Conclusion
Our study is the first to demonstrate that enhanced relative activation of patch-based circuits is observed following METHmediated CPP, and that blockade of patch-based μ opioid receptors can reduce this effect. Our data also showed that the patch-enhanced cFos activation was due in part to a down-regulation of c-Fos activation in the matrix compartment following METH-mediated CPP, suggesting that reward processes could be the result of preferential activation of striatal pathways through the patch compartment that contain information about emotion and motivation, while the activity in striatal pathways through the matrix compartment that mediate behavioral flexibility, leading to behaviors that are inflexible and dependent on internal states. Together, these data indicate that preferential activation of limbic-associated patch-based circuits is necessary for the rewarding effects of METH, and that patch-based μ opioid receptors modulate the activity of the neurons of the patch compartment, leading to diminished METH-mediated reward.
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